Germany approves first trial of COVID-19 Vaccine Candidate

The trial was only the fourth to have been authorised worldwide.

Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.

The trials will see 200 healthy volunteers aged between 18 and 55 years vaccinated with variants of the RNA vaccine, while the second phase could see the inclusion of volunteers who belonged to high-risk groups.

Further clinical trials of COVID-19 vaccine candidates will start in Germany in the next few months.

Please follow and like us:
Pin Share
Show More

Related Articles

Back to top button
error: Content is protected !!